Preparation of New Liposomal Daunorubicin and Evaluation of its Anti-colorectal Cancer in HCT116 Cells
Sign Up to like & getrecommendations! Published in 2024 at "Current Bioactive Compounds"
DOI: 10.2174/0115734072312484241010124144
Abstract: Colorectal cancer (CRC) is the third most common cause of cancerrelated deaths worldwide. To develop more effective anti-CRC drugs, this research evaluated the impact of synthesized liposomal daunorubicin on HTC116 colon cancer cell line. Liposomal… read more here.
Keywords: cancer; daunorubicin; ldnr; liposomal daunorubicin ... See more keywords